These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26031415)

  • 1. Effect of stereotactic dosimetric end points on overall survival for Stage I non-small cell lung cancer: a critical review.
    Mulryan K; Leech M; Forde E
    Med Dosim; 2015; 40(4):340-6. PubMed ID: 26031415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer.
    Merna C; Rwigema JC; Cao M; Wang PC; Kishan AU; Michailian A; Lamb J; Sheng K; Agazaryan N; Low DA; Kupelian P; Steinberg ML; Lee P
    Med Dosim; 2016; 41(1):87-91. PubMed ID: 26755076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
    Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of peer review of volume delineation in stereotactic body radiation therapy planning for primary lung cancer: a multicenter quality assurance study.
    Lo AC; Liu M; Chan E; Lund C; Truong PT; Loewen S; Cao J; Schellenberg D; Carolan H; Berrang T; Wu J; Berthelet E; Olson R
    J Thorac Oncol; 2014 Apr; 9(4):527-33. PubMed ID: 24736076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric evaluation of compensator intensity modulation-based stereotactic body radiotherapy for Stage I non-small-cell lung cancer.
    Tajima Y; Nakayama H; Itonaga T; Shiraishi S; Okubo M; Mikami R; Sugahara S; Tokuuye K
    Br J Radiol; 2015 Aug; 88(1052):20150122. PubMed ID: 25996577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric evaluation of a conformal seven-field coplanar technique for planning lung stereotactic body radiotherapy.
    Richmond N; Green J; Peedell C; Shakespeare D; Walker C
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e24-30. PubMed ID: 21763114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.
    Guckenberger M; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N
    J Thorac Oncol; 2013 Aug; 8(8):1050-8. PubMed ID: 23817193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
    Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
    Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
    Parks J; Kloecker G; Woo S; Dunlap NE
    Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating stereotactic body radiation therapy in stage II/III non-small cell lung cancer: is local control important?
    McGarry RC
    Expert Rev Anticancer Ther; 2014 Dec; 14(12):1419-27. PubMed ID: 25155973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
    Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
    Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
    Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer.
    Ebara T; Shimada H; Kawamura H; Shirai K; Saito J; Kawashima M; Tashiro M; Ohno T; Kanai T; Nakano T
    Anticancer Res; 2014 Sep; 34(9):5099-104. PubMed ID: 25202098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
    Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
    Robinson CG; DeWees TA; El Naqa IM; Creach KM; Olsen JR; Crabtree TD; Meyers BF; Puri V; Bell JM; Parikh PJ; Bradley JD
    J Thorac Oncol; 2013 Feb; 8(2):192-201. PubMed ID: 23287852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB; Grills IS; Kestin LL; Robertson JM
    Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.